Myomo® to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
CAMBRIDGE, Mass. (September 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that its management is scheduled to present at the H.C. Wainwright 22nd Annual Global Investment Conference to be held virtually on […]
Myomo, Inc. to Present at The LD 500 Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Myomo, Inc. (NYSE American), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis today announced that it will be presenting at the LD 500 investor conference on Wednesday, September 2, 2020 at 11:00 a.m. EDT. Chairman […]
Myomo® Extends and Strengthens its Global MyoPro™ Patent Portfolio
New Multi-joint Patents in both U.S. and Europe CAMBRIDGE, Mass. (August 26, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced additional intellectual property protection with the issuance of new patents in the […]
Myomo® Receives First Australian Insurance Authorization for MyoPro™
Additional Authorizations Across Australia are Expected to Follow CAMBRIDGE, Mass. (August 20, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that a Myomo-trained Orthotic & Prosthetic (“O&P”) practice in Australia has received […]
Myomo Reports 2020 Second Quarter Financial Results
Revenue Exceeds Projection as COVID-19 Restrictions Eased Authorization Backlog at Record Level of 120 Units, up 50% Sequentially Conference call begins at 4:30 p.m. Eastern time today CAMBRIDGE, Mass. (August 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from […]
Myomo to Report Second Quarter Financial Results on August 10, 2020
Management to host Financial Results Conference Call at 4:30 p.m. ET CAMBRIDGE, Mass. (August 3, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will report financial results for the […]
Myomo® Launches MyoCare™
New Program Offers Enhanced Support to Maximize the Benefits of MyoPro® to Direct Clients CAMBRIDGE, Mass. (July 9, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the launch of MyoCare™, a new […]
Research Finds MyoPro® Delivers Meaningful Improvements in Motor Function for Brain Injury Patient
Funded by U.S. Department of Defense, Published in Case Report CAMBRIDGE, Mass. (July 6, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that new published research measuring the benefits of the Company’s […]
Myomo Resumes Fitting MyoPro Patients and Deliveries as States Begin to Re-Open after COVID-19 Shutdowns
Q2 Revenue Expected to be in the range of $0.6 million to $0.7 million CAMBRIDGE, Mass. (June 22, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced it has resumed in-person patient visits […]
Myomo® Uses Telehealth Techniques to Conduct Safe Patient Screenings Increased Convenience for Patient Candidates; Increased Productivity and Reduced Costs for Company
CAMBRIDGE, Mass. (June 15, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported the success of its initiative to conduct safe patient screenings remotely using telehealth technologies. Read more.